Beirne Wealth Consulting Services LLC Invests $2.28 Million in UnitedHealth Group Incorporated $UNH

Beirne Wealth Consulting Services LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,601 shares of the healthcare conglomerate’s stock, valued at approximately $2,280,000.

A number of other hedge funds also recently modified their holdings of the business. Crestwood Advisors Group LLC increased its holdings in shares of UnitedHealth Group by 16.0% in the 3rd quarter. Crestwood Advisors Group LLC now owns 5,127 shares of the healthcare conglomerate’s stock valued at $1,770,000 after purchasing an additional 708 shares during the period. Timber Creek Capital Management LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at approximately $2,227,000. NEOS Investment Management LLC grew its holdings in shares of UnitedHealth Group by 44.3% during the 3rd quarter. NEOS Investment Management LLC now owns 117,989 shares of the healthcare conglomerate’s stock valued at $40,742,000 after acquiring an additional 36,236 shares in the last quarter. Heartland Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter worth $326,000. Finally, Holistic Financial Partners grew its stake in UnitedHealth Group by 25.3% in the third quarter. Holistic Financial Partners now owns 1,685 shares of the healthcare conglomerate’s stock valued at $582,000 after purchasing an additional 340 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 3.2%

Shares of NYSE:UNH opened at $293.33 on Tuesday. The stock’s 50-day moving average is $320.31 and its 200-day moving average is $324.02. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a market cap of $265.71 billion, a P/E ratio of 22.24, a P/E/G ratio of 1.35 and a beta of 0.41. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.22 billion for the quarter, compared to analyst estimates of $113.38 billion. During the same quarter last year, the firm posted $6.81 EPS. The company’s revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Piper Sandler reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. Jefferies Financial Group reduced their target price on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a research note on Wednesday, January 28th. Morgan Stanley cut their price target on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating on the stock in a report on Friday, January 23rd. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Finally, Sanford C. Bernstein reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.

View Our Latest Research Report on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.